M LC 450 (Lithium carbonate extended release 450 mg)
Pill imprint M LC 450 has been identified as Lithium carbonate extended release 450 mg.
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; depression; schizoaffective disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M LC 450 (Lithium carbonate extended release 450 mg)
More about lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)